Hepatic myelopathy.
Bourgeois S.
Neurology. 1993 Mar;43(3 Pt 1):629. doi: 10.1212/wnl.43.3_part_1.629.
Hepatic myelopathy neurological complication of chronic liver disease: two case reports.
Mhiri M, Ben Abdelwahed M, Dhiflaoui MA, Ben Dhia R, Gouta N, Jemni I, Baklouti R, Zakhama M, Gueddiche A, Loghmari MH, Ben Chaabene N, Safer L, Frih-Ayed M.
J Med Case Rep. 2024 Jun 17;18(1):281. doi: 10.1186/s13256-024-04495-2.
[Hepatic myelopathy, hepatic neuropathy].
Tsukaguchi M, Takeuchi H.
Ryoikibetsu Shokogun Shirizu. 2000;(29 Pt 4):133-5.
Liver Transplantation Reverses Hepatic Myelopathy in Hepatitis B-Related Decompensated Liver Cirrhosis: Case Report and Review of the Literature.
Zhu Z, Liu Y, Wu W, Huang D, Guo Y, Zheng H, Wang N, Xu Z, Li X, Qin J, Liu L, Nashan B.
Transplant Proc. 2022 Jan-Feb;54(1):158-160. doi: 10.1016/j.transproceed.2021.11.016. Epub 2021 Dec 24.
Hepatic myelopathy improved by embolization of spontaneous portosystemic shunt and partial splenic artery embolization - Literature review.
Liu F, Deng J, Li Z, Huang Z.
Rev Esp Enferm Dig. 2026 Feb;118(2):119-120. doi: 10.17235/reed.2025.11451/2025.
Partial Reversal of Shunt Myelopathy and Hepatic Parkinsonism Using Balloon-Occluded Retrograde Transvenous Obliteration.
Mukund A, Premkumar M, Srivastava A, Baby A, Patidar Y, Sarin S.
Cardiovasc Intervent Radiol. 2024 Jun;47(6):847-851. doi: 10.1007/s00270-024-03729-6. Epub 2024 Apr 22.
Metabolic and Toxic Myelopathies.
Slama MCC, Berkowitz AL.
Semin Neurol. 2021 Jun;41(3):309-326. doi: 10.1055/s-0041-1725150. Epub 2021 May 19.
Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature.
Caldwell C, Werdiger N, Jakab S, Schilsky M, Arvelakis A, Kulkarni S, Emre S.
Liver Transpl. 2010 Jul;16(7):818-26. doi: 10.1002/lt.22077.
[Fluoxetine hydrochloride ameliorates symptoms of hepatic myelopathy: a case report].
Zhang JJ, Gao HR.
Zhonghua Gan Zang Bing Za Zhi. 2024 Nov 20;32(11):1028-1031. doi: 10.3760/cma.j.cn501113-20240131-00069.
Metabolic and Toxic Myelopathies.
Parks NE.
Continuum (Minneap Minn). 2021 Feb 1;27(1):143-162. doi: 10.1212/CON.0000000000000963.
